EICHOR
● Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Condition: Cervical Cancer · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
About this study
This trial is being done to find out whether tisotumab vedotin works better than chemotherapy to treat cervical cancer. People in this study have cervical cancer that has spread to other parts of the body (metastatic) or has come back after being treated (recurrent). Participants in this trial will be randomly assigned to one of two groups. One group will be treated with tisotumab vedotin. Participants in the other group will get one of five different chemotherapy drugs (topotecan, vinorelbine, gemcitabine, pemetrexed, or irinotecan). Participants and their doctors will know which group they are in. Participants in the chemotherapy group will decide with their study doctor which drug they will take.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (211)
| Arizona Oncology Associates, PC - HAL | Glendale, Arizona, United States | — |
| Arizona Oncology Associates P.C. - NAHOA | Phoenix, Arizona, United States | — |
| Arizona Oncology Associates, PC - HAL | Phoenix, Arizona, United States | — |
| Arizona Oncology Associates, PC - HAL | Scottsdale, Arizona, United States | — |
| Arizona Oncology Associates, PC - HAL | Tempe, Arizona, United States | — |
| University of California Irvine Health | Irvine, California, United States | — |
| UC Irvine Health (Investigator Site File Location) | Orange, California, United States | — |
| University of California Irvine Health | Orange, California, United States | — |
| Olive View - UCLA Medical Center | Sylmar, California, United States | — |
| Yale University School of Medicine | New Haven, Connecticut, United States | — |
| Broward Health Medical Center | Fort Lauderdale, Florida, United States | — |
| Georgia Cancer Center at Augusta University | Augusta, Georgia, United States | — |
+ 199 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04697628